51135-96-7 Usage
Description
4-Benzyl-4-hydroxypiperidine is an organic compound that serves as a crucial building block in the synthesis of various compounds with therapeutic properties. It is characterized by its molecular structure, which includes a piperidine ring with a benzyl group and a hydroxyl group attached to the 4-position.
Uses
Used in Pharmaceutical Industry:
4-Benzyl-4-hydroxypiperidine is used as a synthetic building block for the development of various compounds with therapeutic applications. Its versatile structure allows for the creation of a wide range of pharmaceuticals, including those with potential use in the treatment of various medical conditions.
Used in Synthesis of Histamine H3 Antagonists:
4-Benzyl-4-hydroxypiperidine is used as a key intermediate in the synthesis of 4-Benzimidazolyl-piperidinylcarbonyl-piperidine analogs, which are known as histamine H3 antagonists. These compounds have potential applications in the treatment of various conditions, such as cognitive disorders, sleep-wake regulation, and other central nervous system-related issues. The development of histamine H3 antagonists using 4-Benzyl-4-hydroxypiperidine as a building block can lead to the discovery of novel therapeutic agents with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 51135-96-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,1,3 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 51135-96:
(7*5)+(6*1)+(5*1)+(4*3)+(3*5)+(2*9)+(1*6)=97
97 % 10 = 7
So 51135-96-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO/c14-12(6-8-13-9-7-12)10-11-4-2-1-3-5-11/h1-5,13-14H,6-10H2/p+1
51135-96-7Relevant articles and documents
COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISEASES
-
, (2016/10/27)
The present invention refers to relates to compound for treating inflammatory diseases, said formula I compounds represented, such as, a pharmaceutically acceptable salts, or their, or a hydrate thereof is characterized in that the, polymerized. According to the present invention, interacting with-path 5-LOX a compound or interference, in particular 5- oh height[...]width it recovers sourly, in sacrifice, which display inhibitory effects can be provides compounds having. (by machine translation)
ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS
-
Page/Page column 60, (2008/12/05)
The present invention provides Stearoyl CoA Desaturase (SCD) inhibitors, hi particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase 1 (SCD 1) inhibitors. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase (SCD) inhibitors.
Inhibitors of farnesyl-protein transferase
-
, (2008/06/13)
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and treatment of cancer.
